BioVenture VoiCes with Chris Garabedian cover image

Episode 34: General Atlantic's Brett Zbar

BioVenture VoiCes with Chris Garabedian

00:00

Valuation rigor and dilution risk

He explains GA's detailed DCF models and concern about dilution as a key return driver.

Play episode from 33:57
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app